A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
PHASE3
The objective of this study is to evaluate the efficacy and safety of upada...
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
PHASE3
Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, s...
Status
Completed
Location
AZ Arthritis and Rheumotology Research, PLLC - Flagstaff /ID# 253431
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
PHASE3
This study includes two periods. The main objective of Period 1 is to compa...
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
PHASE2
Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes p...